Perheentupa A, Huhtaniemi I
Department of Physiology, University of Turku, Finland.
Endocrinology. 1990 Jun;126(6):3204-9. doi: 10.1210/endo-126-6-3204.
The possibility of direct pituitary effects of sex steroids on gonadotropin gene expression and synthesis was studied in male rats. The animals were treated with a potent GnRH antagonist, Ac-D-pClPhe-D-pClPhe-D-Trp-Ser-Tyr-D-Arg-Leu-Arg-Pro-D-Ala-+ ++NH2CH3COOH (Org 30276; 0.5 mg/kg BW, sc, twice daily) for 10 days. Groups of the antagonist-treated rats were implanted at the beginning of the injections with Silastic capsules containing testosterone (T), 5 alpha-dihydrotestosterone (DHT), or diethylstilbestrol (DES). Groups treated with the antagonist alone or vehicle served as controls. The antagonist treatment decreased unoccupied pituitary receptors of GnRH by 93% (P less than 0.001), serum LH by 34% (P less than 0.01), and serum FSH by 30% (P less than 0.05), and serum T became undetectable (less than 0.10 nmol/liter). Compared to antagonist treatment alone, no further effects on serum or pituitary LH levels found after steroid replacements. In contrast, the antagonist-induced decreases in serum and pituitary FSH (30% and 70%, respectively; P less than 0.05-0.01) were totally reversed by the T and DHT implants, but not by DES. Pituitary levels of the LH beta-subunit mRNA were decreased by 60% (P less than 0.01) after antagonist treatment. Combination treatment with androgens had no further effect on this mRNA, whereas DES partially reversed this suppression (P less than 0.05). In contrast, the pituitary mRNA level of the FSH beta-subunit, which decreased with antagonist treatment by 90% (P less than 0.01), returned to the control level with T and DHT replacements, but only partially with DES. The pituitary mRNA level of the common alpha-subunit was significantly suppressed only by combined antagonist plus DHT treatment (P less than 0.01). However, combination of DES with the antagonist increased alpha-subunit mRNA levels 2.4-fold (P less than 0.05) compared to antagonist treatment alone. It is concluded that the suppression of gonadotropin secretion by GnRH antagonist treatment is accompanied in male rats by a parallel reduction in mRNA levels of the gonadotropin beta-subunits. Sex steroid replacement of the antagonist-treated animals selectively reverses some of the mRNA changes. Androgens (T and DHT) increase the mRNA of FSH beta-subunit, but have no effect on the LH beta-subunit. Estrogen increases the mRNA levels of common alpha- and LH beta-subunits and slightly increases that of FSH beta.(ABSTRACT TRUNCATED AT 400 WORDS)
在雄性大鼠中研究了性类固醇对促性腺激素基因表达和合成的直接垂体效应。给动物注射一种强效促性腺激素释放激素(GnRH)拮抗剂,即Ac-D-pClPhe-D-pClPhe-D-Trp-Ser-Tyr-D-Arg-Leu-Arg-Pro-D-Ala-+ ++NH2CH3COOH(Org 30276;0.5mg/kg体重,皮下注射,每日两次),持续10天。在注射开始时,给接受拮抗剂治疗的大鼠分组植入含睾酮(T)、5α-二氢睾酮(DHT)或己烯雌酚(DES)的硅橡胶胶囊。单独用拮抗剂治疗或用赋形剂处理的组作为对照。拮抗剂治疗使GnRH未占据的垂体受体减少93%(P<0.001),血清促黄体生成素(LH)减少34%(P<0.01),血清促卵泡生成素(FSH)减少30%(P<0.05),血清T变得无法检测(<0.10nmol/L)。与单独拮抗剂治疗相比,类固醇替代后未发现对血清或垂体LH水平有进一步影响。相反,拮抗剂诱导的血清和垂体FSH降低(分别为30%和70%;P<0.05 - 0.01)被T和DHT植入物完全逆转,但未被DES逆转。拮抗剂治疗后垂体LHβ亚基mRNA水平降低60%(P<0.01)。雄激素联合治疗对该mRNA没有进一步影响,而DES部分逆转了这种抑制(P<0.05)。相比之下,拮抗剂治疗使垂体FSHβ亚基mRNA水平降低90%(P<0.01),T和DHT替代后恢复到对照水平,但DES仅部分恢复。仅拮抗剂加DHT联合治疗显著抑制了共同α亚基的垂体mRNA水平(P<0.01)。然而,与单独拮抗剂治疗相比,DES与拮抗剂联合使α亚基mRNA水平增加2.4倍(P<0.05)。结论是,GnRH拮抗剂治疗抑制促性腺激素分泌的同时,雄性大鼠促性腺激素β亚基的mRNA水平也平行降低。拮抗剂治疗动物的性类固醇替代选择性地逆转了一些mRNA变化。雄激素(T和DHT)增加FSHβ亚基的mRNA,但对LHβ亚基没有影响。雌激素增加共同α亚基和LHβ亚基的mRNA水平,并略微增加FSHβ亚基的mRNA水平。(摘要截短至400字)